REIT - Industrial
Compare Stocks
2 / 10Stock Comparison
NHPAP vs NHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
NHPAP vs NHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Industrial | REIT - Healthcare Facilities |
| Market Cap | $602M | $3.58B |
| Revenue (TTM) | $348M | $403M |
| Net Income (TTM) | $-80M | $148M |
| Gross Margin | 36.2% | 61.3% |
| Operating Margin | -4.2% | 48.5% |
| Forward P/E | — | 21.8x |
| Total Debt | $1.15B | $1.16B |
| Cash & Equiv. | $22M | $20M |
NHPAP vs NHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| National Healthcare… (NHPAP) | 100 | 116.7 | +16.7% |
| National Health Inv… (NHI) | 100 | 133.1 | +33.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NHPAP vs NHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NHPAP is the clearest fit if your priority is momentum.
- +63.3% vs NHI's +1.5%
NHI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta -0.08, yield 4.9%
- Rev growth 12.9%, EPS growth -3.5%, 3Y rev CAGR 10.8%
- 60.5% 10Y total return vs NHPAP's 31.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.9% FFO/revenue growth vs NHPAP's 2.3% | |
| Quality / Margins | 36.8% margin vs NHPAP's -23.0% | |
| Stability / Safety | Lower D/E ratio (75.6% vs 166.6%) | |
| Dividends | 4.9% yield, 1-year raise streak, vs NHPAP's 2.3% | |
| Momentum (1Y) | +63.3% vs NHI's +1.5% | |
| Efficiency (ROA) | 5.4% ROA vs NHPAP's -4.6%, ROIC 5.6% vs -4.8% |
NHPAP vs NHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NHPAP vs NHI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NHI and NHPAP operate at a comparable scale, with $403M and $348M in trailing revenue. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to NHPAP's -23.0%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $348M | $403M |
| EBITDAEarnings before interest/tax | $72M | $282M |
| Net IncomeAfter-tax profit | -$80M | $148M |
| Free Cash FlowCash after capex | -$125M | $226M |
| Gross MarginGross profit ÷ Revenue | +36.2% | +61.3% |
| Operating MarginEBIT ÷ Revenue | -4.2% | +48.5% |
| Net MarginNet income ÷ Revenue | -23.0% | +36.8% |
| FCF MarginFCF ÷ Revenue | -35.9% | +56.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | +29.7% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +10.8% |
Valuation Metrics
NHPAP leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $602M | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $4.7B |
| Trailing P/EPrice ÷ TTM EPS | -2.96x | 24.46x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.82x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 16.96x |
| Price / SalesMarket cap ÷ Revenue | 1.70x | 9.46x |
| Price / BookPrice ÷ Book value/share | 0.87x | 2.26x |
| Price / FCFMarket cap ÷ FCF | — | 16.26x |
Profitability & Efficiency
NHI leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-12 for NHPAP. NHI carries lower financial leverage with a 0.76x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHPAP's 1.67x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs NHPAP's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -12.3% | +9.8% |
| ROA (TTM)Return on assets | -4.6% | +5.4% |
| ROICReturn on invested capital | -4.8% | +5.6% |
| ROCEReturn on capital employed | -7.7% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 1.67x | 0.76x |
| Net DebtTotal debt minus cash | $1.1B | $1.1B |
| Cash & Equiv.Liquid assets | $22M | $20M |
| Total DebtShort + long-term debt | $1.1B | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | -1.78x | 3.45x |
Total Returns (Dividends Reinvested)
NHI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHI five years ago would be worth $12,946 today (with dividends reinvested), compared to $12,254 for NHPAP. Over the past 12 months, NHPAP leads with a +63.3% total return vs NHI's +1.5%. The 3-year compound annual growth rate (CAGR) favors NHI at 19.6% vs NHPAP's 12.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +19.9% | -2.7% |
| 1-Year ReturnPast 12 months | +63.3% | +1.5% |
| 3-Year ReturnCumulative with dividends | +43.8% | +71.1% |
| 5-Year ReturnCumulative with dividends | +22.5% | +29.5% |
| 10-Year ReturnCumulative with dividends | +31.5% | +60.5% |
| CAGR (3Y)Annualised 3-year return | +12.9% | +19.6% |
Risk & Volatility
Evenly matched — NHPAP and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than NHPAP's 0.17 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHPAP currently trades 95.9% from its 52-week high vs NHI's 81.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.17x | -0.08x |
| 52-Week HighHighest price in past year | $22.17 | $90.94 |
| 52-Week LowLowest price in past year | $13.42 | $68.80 |
| % of 52W HighCurrent price vs 52-week peak | +95.9% | +81.2% |
| RSI (14)Momentum oscillator 0–100 | 66.3 | 23.8 |
| Avg Volume (50D)Average daily shares traded | 9K | 330K |
Analyst Outlook
NHI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, NHI offers the higher dividend yield at 4.88% vs NHPAP's 2.29%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $85.40 |
| # AnalystsCovering analysts | — | 18 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | +4.9% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.49 | $3.61 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
NHI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NHPAP leads in 1 (Valuation Metrics). 1 tied.
NHPAP vs NHI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is NHPAP or NHI a better buy right now?
For growth investors, National Health Investors, Inc.
(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). National Health Investors, Inc. (NHI) offers the better valuation at 24. 5x trailing P/E (21. 8x forward), making it the more compelling value choice. Analysts rate National Health Investors, Inc. (NHI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NHPAP or NHI?
Over the past 5 years, National Health Investors, Inc.
(NHI) delivered a total return of +29. 5%, compared to +22. 5% for National Healthcare Properties, Inc. (NHPAP). Over 10 years, the gap is even starker: NHI returned +60. 5% versus NHPAP's +31. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NHPAP or NHI?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus National Healthcare Properties, Inc. 's 0. 17β — meaning NHPAP is approximately -305% more volatile than NHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 167% for National Healthcare Properties, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — NHPAP or NHI?
By revenue growth (latest reported year), National Health Investors, Inc.
(NHI) is pulling ahead at 12. 9% versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). On earnings-per-share growth, the picture is similar: National Health Investors, Inc. grew EPS -3. 5% year-over-year, compared to -136. 5% for National Healthcare Properties, Inc.. Over a 3-year CAGR, NHI leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NHPAP or NHI?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus -53. 6% for National Healthcare Properties, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -34. 9% for NHPAP. At the gross margin level — before operating expenses — NHPAP leads at 37. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NHPAP or NHI?
All stocks in this comparison pay dividends.
National Health Investors, Inc. (NHI) offers the highest yield at 4. 9%, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP).
07Is NHPAP or NHI better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +60. 5%, NHPAP: +31. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NHPAP and NHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NHPAP is a small-cap quality compounder stock; NHI is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.